Moderna said Thursday that it asked the Food and Drug Administration for emergency use authorization of its COVID-19 vaccine in kids under age 6, making it the first drug company to do so.
The long-awaited announcement has been monitored closely by lawmakers, public health advocates and parents hoping to protect toddlers and babies against the virus. Pfizer is expected to soon follow Moderna and submit an emergency use application for its vaccine.
The request is based on a 25-microgram two-dose primary series and the application will be complete next week, the company said.
